L7 Informatics, an Austin, Texas-based provider of solutions for enterprise-scale digital transformation and automation of scientific processes in the life sciences and healthcare domains, closed its $13M Series B financing round.
The round was led by previous investors along with several new investors, including Phoenix Venture Partners.
The company intends to use the funds to accelerate the commercialization of its platform.
Led by CEO Dr. Vasu Rangadass, L7 Informatics provides Enterprise Science Platform™ (L7|ESP™), a software platform that simplifies data management, digitalizes and automates workflows in the therapeutics, diagnostics, medicine, research, and agrochemical industries, in order to enable efficiencies, compliance, reduced costs, and improved operational velocity.
FinSMEs
08/03/2021